“Predicting outcomes with pembrolizumab: a meta-analysis of pre-treatment hematological and clinical prognostic factors in advanced/metastatic urothelial carcinoma”, Arch Ital Urol Androl, vol. 97, no. 2, Jun. 2025, doi: 10.4081/aiua.2025.13880.